This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-107 | PTGIS | 1.31 | 0 | -4.49 | 0 | miRanda | -1.82 | 0 | NA | |
2 | hsa-miR-330-5p | PTGIS | 1.15 | 0 | -4.49 | 0 | miRanda | -1.18 | 0 | NA | |
3 | hsa-miR-34c-5p | PTGIS | 2.07 | 0 | -4.49 | 0 | miRanda | -0.27 | 0.00418 | NA | |
4 | hsa-miR-429 | PTGIS | 4.49 | 0 | -4.49 | 0 | miRNATAP | -0.57 | 0 | NA | |
5 | hsa-miR-532-3p | PTGIS | 1.97 | 0 | -4.49 | 0 | miRNATAP | -1.09 | 0 | NA | |
6 | hsa-miR-590-3p | PTGIS | 2.59 | 0 | -4.49 | 0 | miRanda | -1.13 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SMALL MOLECULE METABOLIC PROCESS | 18 | 1767 | 5.493e-13 | 2.556e-09 |
2 | COFACTOR METABOLIC PROCESS | 9 | 334 | 4.74e-10 | 8.778e-07 |
3 | SINGLE ORGANISM BIOSYNTHETIC PROCESS | 14 | 1340 | 5.659e-10 | 8.778e-07 |
4 | OXIDATION REDUCTION PROCESS | 12 | 898 | 9.765e-10 | 1.136e-06 |
5 | SMALL MOLECULE BIOSYNTHETIC PROCESS | 9 | 443 | 5.628e-09 | 5.237e-06 |
6 | MONOCARBOXYLIC ACID METABOLIC PROCESS | 9 | 503 | 1.692e-08 | 1.142e-05 |
7 | LIPID METABOLIC PROCESS | 12 | 1158 | 1.718e-08 | 1.142e-05 |
8 | LIPID BIOSYNTHETIC PROCESS | 9 | 539 | 3.069e-08 | 1.785e-05 |
9 | CELLULAR KETONE METABOLIC PROCESS | 5 | 68 | 3.618e-08 | 1.871e-05 |
10 | COENZYME METABOLIC PROCESS | 7 | 265 | 6.183e-08 | 2.877e-05 |
11 | QUINONE METABOLIC PROCESS | 4 | 29 | 7.124e-08 | 3.013e-05 |
12 | FAT SOLUBLE VITAMIN METABOLIC PROCESS | 4 | 32 | 1.075e-07 | 4.17e-05 |
13 | ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 8 | 482 | 2.184e-07 | 7.567e-05 |
14 | CELLULAR LIPID METABOLIC PROCESS | 10 | 913 | 2.318e-07 | 7.567e-05 |
15 | ORGANONITROGEN COMPOUND METABOLIC PROCESS | 13 | 1796 | 2.439e-07 | 7.567e-05 |
16 | SINGLE ORGANISM CATABOLIC PROCESS | 10 | 957 | 3.583e-07 | 0.0001042 |
17 | VITAMIN METABOLIC PROCESS | 5 | 120 | 6.293e-07 | 0.0001722 |
18 | STEROID METABOLIC PROCESS | 6 | 237 | 7.871e-07 | 0.0002035 |
19 | ORGANIC ACID METABOLIC PROCESS | 9 | 953 | 3.709e-06 | 0.0009082 |
20 | SMALL MOLECULE CATABOLIC PROCESS | 6 | 328 | 5.164e-06 | 0.001201 |
21 | ALCOHOL METABOLIC PROCESS | 6 | 348 | 7.247e-06 | 0.001606 |
22 | CIRCULATORY SYSTEM PROCESS | 6 | 366 | 9.661e-06 | 0.001932 |
23 | SODIUM ION HOMEOSTASIS | 3 | 30 | 9.727e-06 | 0.001932 |
24 | GLYCOSYL COMPOUND METABOLIC PROCESS | 6 | 368 | 9.966e-06 | 0.001932 |
25 | OXIDOREDUCTION COENZYME METABOLIC PROCESS | 4 | 107 | 1.436e-05 | 0.002628 |
26 | PURINE CONTAINING COMPOUND METABOLIC PROCESS | 6 | 394 | 1.468e-05 | 0.002628 |
27 | ALCOHOL BIOSYNTHETIC PROCESS | 4 | 111 | 1.66e-05 | 0.002861 |
28 | STEROID BIOSYNTHETIC PROCESS | 4 | 114 | 1.844e-05 | 0.003065 |
29 | ORGANOPHOSPHATE METABOLIC PROCESS | 8 | 885 | 2.008e-05 | 0.003222 |
30 | GLUCOSE METABOLIC PROCESS | 4 | 119 | 2.184e-05 | 0.003279 |
31 | LIPID CATABOLIC PROCESS | 5 | 247 | 2.15e-05 | 0.003279 |
32 | STEROL METABOLIC PROCESS | 4 | 123 | 2.488e-05 | 0.003617 |
33 | STEROL BIOSYNTHETIC PROCESS | 3 | 43 | 2.921e-05 | 0.004119 |
34 | REGULATION OF VASODILATION | 3 | 48 | 4.075e-05 | 0.005576 |
35 | FATTY ACID METABOLIC PROCESS | 5 | 296 | 5.103e-05 | 0.006595 |
36 | REGULATION OF BLOOD CIRCULATION | 5 | 295 | 5.021e-05 | 0.006595 |
37 | CELLULAR LIPID CATABOLIC PROCESS | 4 | 151 | 5.552e-05 | 0.006981 |
38 | HEXOSE METABOLIC PROCESS | 4 | 157 | 6.461e-05 | 0.007911 |
39 | CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 8 | 1047 | 6.673e-05 | 0.007962 |
40 | NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 6 | 535 | 8.128e-05 | 0.009005 |
41 | MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 3 | 60 | 7.972e-05 | 0.009005 |
42 | COFACTOR BIOSYNTHETIC PROCESS | 4 | 166 | 8.022e-05 | 0.009005 |
43 | CATABOLIC PROCESS | 10 | 1773 | 8.623e-05 | 0.009331 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | TETRAPYRROLE BINDING | 6 | 134 | 2.698e-08 | 2.506e-05 |
2 | OXIDOREDUCTASE ACTIVITY | 9 | 719 | 3.566e-07 | 0.0001656 |
3 | MONOOXYGENASE ACTIVITY | 4 | 95 | 8.962e-06 | 0.002775 |
4 | NADP BINDING | 3 | 44 | 3.132e-05 | 0.007274 |
5 | OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 4 | 155 | 6.146e-05 | 0.009517 |
6 | INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 3 | 53 | 5.493e-05 | 0.009517 |
7 | IRON ION BINDING | 4 | 163 | 7.474e-05 | 0.009919 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 11 | 1005 | 4.766e-08 | 2.293e-05 |
2 | ENDOPLASMIC RETICULUM | 13 | 1631 | 7.854e-08 | 2.293e-05 |
3 | ENDOPLASMIC RETICULUM PART | 11 | 1163 | 2.104e-07 | 4.096e-05 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | cAMP_signaling_pathway_hsa04024 | 2 | 198 | 0.03114 | 0.7103 |